Has Carmelo Otero, MD received payments from drug or device companies?

Yes. Drug and device makers reported $32,329 in general payments to Carmelo Otero, MD across 140 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Carmelo Otero, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Carmelo Otero, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Carmelo Otero, MD

Surgery · San Antonio, TXNPI 1588683155

Payments from drug & device makers

What this record shows

This record is dominated by other: $23,222 of the $32,329 with a category attached, or 71.8%. Angiodynamics, Inc. accounts for 74.0% of it on its own, with 43 other manufacturers making up the rest. Among surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$32,329in general payments, 2019–2025

Across 140 payments — averaging $230.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Angiodynamics, Inc.$24K
Baxter Healthcare$3K
OPKO Pharmaceuticals, LLC$586
Philips North America LLC$579
Bard Peripheral Vascular, Inc.$547
Shockwave Medical, Inc$372
plus $3K from 38 others

What the payments were for

Consulting fees$2,8269%
Food & beverage$6,28119%
Other$23,22272%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Angiodynamics, Inc.	21	$23,909
Baxter Healthcare	3	$3,040
OPKO Pharmaceuticals, LLC	5	$586
Philips North America LLC	16	$579
Bard Peripheral Vascular, Inc.	12	$547
Shockwave Medical, Inc	3	$372
Mallinckrodt Hospital Products Inc.	9	$260
Fresenius USA Marketing, Inc.	10	$212
Akebia Therapeutics Inc	2	$177
Mallinckrodt Enterprises LLC	3	$158
Kerecis Limited	1	$140
Medela LLC	2	$135
Cardiovascular Systems Inc.	5	$135
W. L. Gore & Associates, Inc.	2	$130
Bayer	1	$125
Lilly USA, LLC	1	$122
Penumbra, Inc.	1	$121
Aurinia Pharma U.S., Inc.	2	$120
Abbott	3	$118
AstraZeneca	1	$116
Lemaitre Vascular, Inc.	4	$115
Corcept Therapeutics	1	$108
Calliditas Therapeutics US Inc.	1	$106
Sonavex, Inc.	1	$87
Amgen	1	$86
Smith+Nephew	3	$76
Nxstage Medical, Inc.	2	$69
Boston Scientific	3	$67
Asahi Intecc USA, Inc.	1	$58
Endologix LLC	1	$50
Novartis	3	$49
Inari Medical, Inc.	2	$45
Acist Medical Systems, Inc.	1	$45
Saranas, Inc.	1	$39
Cook Medical LLC	2	$37
Acera Surgical, Inc.	2	$36
Organogenesis Inc.	1	$25
Cvrx, Inc.	1	$25
Tactile Systems Technology Inc	1	$22
Cormedix Inc.	1	$20
ANI Pharmaceuticals, Inc.	1	$18
Novo Nordisk	1	$16
Vifor Pharma, Inc.	1	$15
Medtronic	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Auryon Laser System 100-120 Vac$23,368
SEPRAFILM$2,826
Rayaldee$488
Kerecis Omega3 SurgiClose$419
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$372
ACTHAR$236
Kerecis Omega3 GraftGuide$140
Kerecis Omega3 Marigen$140
Lasers$138
Turbo Elite$125
AURYXIA$125
Kerendia$125
MOUNJARO$122
Indigo System$121
Non-Franchise (NOF) - NonProduct$117
LOKELMA$116
Korlym$108
GORE EXCLUDER AAA Endoprosthesis$107
TARPEYO$106

How this compares

$32,329 in reported general payments places this provider in the 90th percentile of 1,830 surgery providers in Texas.

See all surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$255,602

Medicare patients

315

Services billed

1,485

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	11	$5,708
ClopidogrelClopidogrel Bisulfate	106	$1,201
Acetaminophen-CodeineAcetaminophen With Codeine	74	$549
Lidocaine-PrilocaineLidocaine/Prilocaine	12	$160
Ciprofloxacin Hcl	18	$118
Tramadol Hcl	12	$60

Paid to pharmacies, not to this prescriber.

Other surgery in San Antonio

Richard PetersonSan Antonio$323K
Joseph KaramSan Antonio$293K
John PilcherSan Antonio$214K
John MeterskySan Antonio$158K
Kent van SickleSan Antonio$143K
Richard EnglehardtSan Antonio$107K
Guillermo Portillo RamilaSan Antonio$102K
Michael HarkinsTomball$2.7M
Douglas StoddardAustin$1.4M
Steven FassAustin$989K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →